A first-in-human study of Brozopentyl Sodium, following single and multiple ascending intravenous infusion in Chinese healthy volunteers.

Sheng, Xiao-Yan; Xie, Ran; Wei, Lu-Hua; Jia, Bo; Li, Yun-Feng; Zheng, Zhi-Guo; Zhao, Xia; Cui, Yi-Min

Sheng, Xiao-Yan; Xie, Ran; Wei, Lu-Hua; Jia, Bo; Li, Yun-Feng; Zheng, Zhi-Guo; Zhao, Xia; Cui, Yi-Min.

Affiliation

Sheng XY; Department of Pharmacy, Peking University First Hospital, Beijing, China.
Xie R; Drug Clinical Trial Institution, Peking University First Hospital, Beijing, China.
Wei LH; Department of Neurology, Peking University First Hospital, Beijing, China.
Jia B; Drug Clinical Trial Institution, Peking University First Hospital, Beijing, China.
Li YF; Zhejiang Ausun Pharmaceutical Co., Ltd., Zhejiang, China.
Zheng ZG; Zhejiang Ausun Pharmaceutical Co., Ltd., Zhejiang, China.
Zhao X; Drug Clinical Trial Institution, Peking University First Hospital, Beijing, China. Electronic address: zxyjk@126.com.
Cui YM; Department of Pharmacy, Peking University First Hospital, Beijing, China; Institute of Clinical Pharmacology, Peking University First Hospital, Beijing, China. Electronic address: cui.pharm@pkufh.com.

Eur J Pharm Sci ; 192: 106663, 2024 Jan 01.

Article in En | MEDLINE | ID: mdl-38056780

Subject(s)
Key words

Brozopentyl Sodium (BZP); Chinese subjects; First-in-human; Pharmacokinetics; Safety

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sodium / Ischemic Stroke Limits: Humans Country/Region as subject: Asia Language: En Journal: Eur J Pharm Sci Journal subject: FARMACIA / FARMACOLOGIA / QUIMICA Year: 2024 Document type: Article Affiliation country: China Country of publication: Países Bajos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google